glp-1 agonist. PDB-101: Molecule of the Month: Receptor Agonists Glucagon-like peptide-1 receptor: mechanisms and
Description
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet supplemented with Extra-virgin Olive oil or nuts
Reproduced from Wikipedia Commons
However, Novo Nordisk is expected to emerge as the leading company, having a large portfolio of GLP1 drugs, and is expected to capture 55 per cent of the market share in 2029.
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Proc Natl Acad Sci U S A (1987) 84:34348
